About These Training

HEDIS Essential Update For Reporting 

This four part series presented by NCQA staff gives you an inside look at current HEDIS requirements and a sneak peek at changes on the horizon for the future.

 Advancing Health Equity with HEDIS: What's New and Looking Forward 

NCQA subject matter experts will review our efforts to advance equity in HEDIS so far. This will include a discussion of frequently asked questions, the state of equity data and alignment with other measurement efforts in the field. NCQA will also preview upcoming Equity in HEDIS efforts for MY 2025 and beyond

HEDIS Reporting Results 

NCQA will share the latest reporting results for 14 measures collected via the HEDIS Electronic Clinical Data Systems (ECDS) reporting standard as well as first-year results for four measures.

HEDIS MY 2024 Updates & What's coming for MY 2025 and Beyond 

NCQA will review and discuss updates for HEDIS MY 2024 as they relate to the HEDIS Volume 2. NCQA will also provide a preview on what's coming for MY 2025 and beyond. This will include new measure development, potential changes to existing measures and overall volume 2 changes.

Reporting HEDIS MY 2023: Audit and Data Submission Considerations to Have on Your Radar

NCQA will provide an orientation to the HEDIS Compliance Audit, describe ongoing program updates, and highlight key milestones for HEDIS MY 2023 reporting season.

What You will learn

• Discuss updates for HEDIS MY 2024 as they relate to the HEDIS Volume 2 Technical Update and Audit and Data Collection requirements.
• Summarize NCQA’s strategy and discuss key findings to leverage electronic clinical data in HEDIS.
• Summarize and Outline NCQA updated template for HEDIS measure specifications.
• Summarize the HEDIS Compliance Audit goals and process.

HEDIS^® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Who Should Attend

This program is for the those who are responsible for gathering, analyzing, assessing or reporting HEDIS data, including (but not limited to): 

• Quality Improvement Managers/Directors 
• HEDIS Data Analyst 
• HEDIS Program Managers/Directors 
• Clinical Audit Coordinator 

Faculty

Cindy Ottone, HMA, Director, Measures Policy

Rachel Harrington, Senior Applied Research Scientist, Health Equity, NCQA

Keirsha Thompson, Manager, Performance Measurement, NCQA

Adrianna Nava, Research Scientist, Performance Measurement, NCQA

Fern McCree, Senior Research Associate, Performance Measurement, NCQA

Taylor Musser, Director, Measure Collection  & Audit,  Measure Validation, NCQA

Pam Lighter, Director, Research & Analysis, Performance Measurement

Lyndsey Nguyen, Senior Health Care Analyst, Performance Measurement

Kristen Bishop, Senior Health Care Analyst, Performance Measurement

Brenna Lin, Senior Research Associate, Performance Measurement

Danielle Rainis, Senior Health Care Analyst, Performance Measurement

Emily Hubbard, Senior Health Care Analyst, Performance Measurement

Gabby Kyle-Lion, Senior Health Care Analyst, Performance Measurement

Myra Masood, Senior Health Care Analyst, Performance Measurement

Jules Reich, Senior Health Care Analyst, Performance Measurement

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations.

For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution.  For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist with the following companies/organizations: